Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias

The survey of early-onset dementia was done in five prefectures and two cities in all parts of Japan from 2006 to 2008. The estimated number of patients per 100,000 in the 18–64-year-old population was 47.6 (95% confidence interval (CI): 45.5–49.7). The estimated patient number in all of Japan was calculated to be 37,800 (95% CI: 36,100–39,400). As a result, we found that vascular dementia (VaD) was the most common illness causing dementia, followed by Alzheimer’s disease (AD), posttraumatic syndrome, and then frontotemporal degeneration. The prevalence of late-onset dementia was surveyed with in ten areas in all parts of Japan from 2009 to 2012. From the results, the estimated national prevalence was 15%, with a standard error of 0.0136 and 95% CI of 0.12, 0.17. The number of people with dementia in all of Japan was estimated to be about 4.62 million out of a population of 30.79 million people (definite value) aged 65 years and older as of October 1, 2012. The number had probably reached 50 million by the end of 2014. For the immediate future, both the prevalence and the total number of dementia patients are expected to rise steadily with the increase in the mean life expectancy.

[1]  Sabine Van Huffel,et al.  An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES , 2007, NMR in biomedicine.

[2]  W. Lowe,et al.  Osmotic regulation of Na-myo-inositol cotransporter mRNA level and activity in endothelial and neural cells. , 1996, The American journal of physiology.

[3]  C. Gandolfo,et al.  Kinetics of creatine in blood and brain after intraperitoneal injection in the rat , 2003, Brain Research.

[4]  Ranjan Duara,et al.  Conversion to Dementia among Two Groups with Cognitive Impairment , 2004, Dementia and Geriatric Cognitive Disorders.

[5]  B. Meier,et al.  Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .

[6]  Klaas Nicolay,et al.  1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.

[7]  H. Betz,et al.  The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues. , 1994, Biochemical and biophysical research communications.

[8]  K. Kiuchi,et al.  Fractional Anisotropy–Threshold Dependence in Tract-Based Diffusion Tensor Analysis: Evaluation of the Uncinate Fasciculus in Alzheimer Disease , 2009, American Journal of Neuroradiology.

[9]  Stephen K Fisher,et al.  Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance , 2002, Journal of neurochemistry.

[10]  F. Palmer,et al.  Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. , 1989, Biochimica et biophysica acta.

[11]  D. A. Godfrey,et al.  Distribution of myo‐Inositol in the Cat Cochlear Nucleus , 1982, Journal of neurochemistry.

[12]  D van Ormondt,et al.  Cramér–Rao bounds: an evaluation tool for quantitation , 2001, NMR in biomedicine.

[13]  N. Fayed,et al.  Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study , 2011, BMJ Open.

[14]  J. Shapiro,et al.  Effects of hypernatremia on organic brain osmoles. , 1990, The Journal of clinical investigation.

[15]  J. McCracken,et al.  Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder , 2001, Neuropsychopharmacology.

[16]  Khadija Iqbal,et al.  Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Olaf Sporns,et al.  The Human Connectome: A Structural Description of the Human Brain , 2005, PLoS Comput. Biol..

[18]  S. Van Huffel,et al.  Lineshape estimation for magnetic resonance spectroscopy (MRS) signals: self-deconvolution revisited , 2009 .

[19]  Anthony J. Spychalla,et al.  Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy , 2014, The Journal of Neuroscience.

[20]  L. Martí-Bonmatí,et al.  Cognitive impairment: classification by 1H magnetic resonance spectroscopy , 2004, European journal of neurology.

[21]  R. Edelman,et al.  Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. , 2004, AJNR. American journal of neuroradiology.

[22]  W. Markesbery,et al.  Neuropathologic alterations in mild cognitive impairment: a review. , 2010, Journal of Alzheimer's disease : JAD.

[23]  J. Neale,et al.  Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes , 2006, Journal of neurochemistry.

[24]  J. Moll,et al.  Contribution of 1H Spectroscopy to a Brief Cognitive-Functional Test Battery for the Diagnosis of Mild Alzheimer’s Disease , 2012, Dementia and Geriatric Cognitive Disorders.

[25]  William S. Ball,et al.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. , 2001, American journal of human genetics.

[26]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[27]  B. Reisberg,et al.  Mild cognitive impairment in the elderly , 1991, Neurology.

[28]  M. Goldberg,et al.  Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes , 2001, The Journal of Neuroscience.

[29]  Zenon Starčuk,et al.  Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package , 2009 .

[30]  T. Taoka,et al.  Global and region-specific analyses of apparent diffusion coefficient in dentatorubral-pallidoluysian atrophy. , 2006, AJNR. American journal of neuroradiology.

[31]  A. Yamauchi,et al.  Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. , 1992, The Journal of biological chemistry.

[32]  J. Parrish,et al.  Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. , 1999, The American journal of psychiatry.

[33]  N. Fayed,et al.  Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. , 2008, Academic radiology.

[34]  D M Doddrell,et al.  A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. , 1999, Magnetic resonance imaging.

[35]  R. Gruetter,et al.  Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin‐induced diabetic rats , 2009, Journal of neurochemistry.

[36]  M. Norenberg,et al.  Osmotic regulation ofmyo-inositol uptake in primary astrocyte cultures , 1994, Neurochemical Research.

[37]  Liang Peng,et al.  Energy Metabolism in Astrocytes: High Rate of Oxidative Metabolism and Spatiotemporal Dependence on Glycolysis/Glycogenolysis , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  James S Babb,et al.  Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease. , 2013, Magnetic resonance imaging.

[39]  R. Kreis Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.

[40]  R. Belmaker,et al.  Valproate decreases inositol biosynthesis , 2004, Biological Psychiatry.

[41]  A. Urazaev,et al.  N-Acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber , 2001, Neuroscience.

[42]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[43]  Michael Weiner,et al.  Breakdown of Brain Connectivity Between Normal Aging and Alzheimer's Disease: A Structural k-Core Network Analysis , 2013, Brain Connect..

[44]  C. Jack,et al.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. , 2008, Radiology.

[45]  N. Schuff,et al.  Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging , 2006, Alzheimer disease and associated disorders.

[46]  Liang Peng,et al.  Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH , 2012, Neurochemistry International.

[47]  R. Blakely,et al.  Expression of the rat brain creatine transporter in situ and in transfected HeLa cells. , 1996, Developmental neuroscience.

[48]  F. Jessen,et al.  Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients , 2001, Neurology.

[49]  J. Konvalinka,et al.  Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer , 2006, The EMBO journal.

[50]  E. Tangalos,et al.  Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[51]  Alexander Leemans,et al.  Disruption of cerebral networks and cognitive impairment in Alzheimer disease , 2013, Neurology.

[52]  P. Comfurius,et al.  Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.

[53]  R S Menon,et al.  Spectroscopic lineshape correction by QUECC: Combined QUALITY deconvolution and eddy current correction , 2000, Magnetic resonance in medicine.

[54]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[55]  Sabine Van Huffel,et al.  Java-based framework for processing and displaying short-echo-time magnetic resonance spectroscopy signals , 2007, Comput. Methods Programs Biomed..

[56]  Guy B. Williams,et al.  Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. , 2011, Brain : a journal of neurology.

[57]  Heinrich Lanfermann,et al.  Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy , 2009, Psychiatry Research: Neuroimaging.

[58]  M. Albert,et al.  Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. , 2012, The Journal of neuropsychiatry and clinical neurosciences.

[59]  Mojtaba Zarei,et al.  White matter tract integrity in aging and Alzheimer's disease , 2009, Human brain mapping.

[60]  R. Morris,et al.  The relationship between white matter brain metabolites and cognition in normal aging: The GENIE study , 2007, Brain Research.

[61]  K. Kantarci Magnetic resonance spectroscopy in common dementias. , 2013, Neuroimaging clinics of North America.

[62]  D. Dubowitz,et al.  Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain , 1998, Magnetic Resonance in Medicine.

[63]  D. Le Bihan,et al.  Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. , 1999, Stroke.

[64]  R. Koehler,et al.  Astrocyte glutamine synthetase: Importance in hyperammonemic syndromes and potential target for therapy , 2010, Neurotherapeutics.

[65]  R. Kauppinen,et al.  Nondestructive Detection of Glutamate by 1H Nuclear Magnetic Resonance Spectroscopy in Cortical Brain Slices from the Guinea Pig: Evidence for Changes in Detectability During Severe Anoxic Insults , 1991, Journal of neurochemistry.

[66]  J. Lapointe,et al.  Effects of hyperosmolarity on the Na+ -myo-inositol cotransporter SMIT2 stably transfected in the Madin-Darby canine kidney cell line. , 2008, American journal of physiology. Cell physiology.

[67]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[68]  C. Barnes,et al.  Age-related changes in parahippocampal white matter integrity: A diffusion tensor imaging study , 2012, Neuropsychologia.

[69]  Masaaki Hori,et al.  Visualizing non-Gaussian diffusion: clinical application of q-space imaging and diffusional kurtosis imaging of the brain and spine. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[70]  P. Kaldis,et al.  'Hot spots' of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus. , 1996, Developmental neuroscience.

[71]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[72]  C Bachmann,et al.  Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. , 2001, Brain research. Molecular brain research.

[73]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[74]  J. Chatton,et al.  Identification of a mammalian H+‐myo‐inositol symporter expressed predominantly in the brain , 2001, The EMBO journal.

[75]  Linda Chang,et al.  Regional variations and the effects of age and gender on glutamate concentrations in the human brain. , 2008, Magnetic resonance imaging.

[76]  Timothy Edward John Behrens,et al.  Automated Probabilistic Reconstruction of White-Matter Pathways in Health and Disease Using an Atlas of the Underlying Anatomy , 2011, Front. Neuroinform..

[77]  Rolf Gruetter,et al.  Handling macromolecule signals in the quantification of the neurochemical profile. , 2012, Journal of Alzheimer's disease : JAD.

[78]  Lawrence R. Frank,et al.  Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis , 2009, NeuroImage.

[79]  Masahiko Watanabe,et al.  The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  H. Henry,et al.  Expression and function of AGAT, GAMT and CT1 in the mammalian brain. , 2007, Sub-cellular biochemistry.

[81]  A. Schousboe,et al.  1 Glutamine, Glutamate, and GABA: Metabolic Aspects , 2007 .

[82]  H. Happe,et al.  In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system , 1995, The Journal of comparative neurology.

[83]  S. Van Huffel,et al.  Different quantification algorithms may lead to different results: a comparison using proton MRS lipid signals , 2014, NMR in biomedicine.

[84]  P. Steiner,et al.  Regulated exocytosis of an H+/myo‐inositol symporter at synapses and growth cones , 2004, The EMBO journal.

[85]  M. Portero-Otín,et al.  Non-Enzymatic Modification of Aminophospholipids by Carbonyl-Amine Reactions , 2013, International journal of molecular sciences.

[86]  T. Taoka,et al.  Diffusion anisotropy and diffusivity of white matter tracts within the temporal stem in Alzheimer disease: evaluation of the "tract of interest" by diffusion tensor tractography. , 2006, AJNR. American journal of neuroradiology.

[87]  J. Molinuevo,et al.  Longitudinal Study of Amnesic Patients at High Risk for Alzheimer’s Disease: Clinical, Neuropsychological and Magnetic Resonance Spectroscopy Features , 2007, Dementia and Geriatric Cognitive Disorders.

[88]  C. Jack,et al.  MRI and MRS predictors of mild cognitive impairment in a population-based sample , 2013, Neurology.

[89]  Barbara Palumbo,et al.  Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging , 1997, Mechanisms of Ageing and Development.

[90]  Huaxi Xu,et al.  APP processing in Alzheimer's disease , 2011, Molecular Brain.

[91]  P. V. van Zijl,et al.  Comparison of single‐shot localization methods (steam and press) for In vivo proton NMR spectroscopy , 1989, NMR in biomedicine.

[92]  Andrew Simmons,et al.  Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. , 2010, Journal of Alzheimer's disease : JAD.

[93]  Peter Mattsson,et al.  Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1h magnetic resonance spectroscopy (MRS) study , 2010, Acta radiologica.

[94]  B. Miller,et al.  White matter damage in primary progressive aphasias: a diffusion tensor tractography study. , 2011, Brain : a journal of neurology.

[95]  Anders H. Andersen,et al.  Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease , 2010, NeuroImage.

[96]  A. Mitchell,et al.  Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.

[97]  K. Bushara,et al.  Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status , 2010, Movement disorders : official journal of the Movement Disorder Society.

[98]  Massimo Filippi,et al.  White matter damage in Alzheimer disease and its relationship to gray matter atrophy. , 2011, Radiology.

[99]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[100]  R. Augustin The protein family of glucose transport facilitators: It's not only about glucose after all , 2010, IUBMB life.

[101]  S. Nakanishi,et al.  Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb , 1993, Nature.

[102]  N. Herrmann,et al.  Mild Cognitive Impairment: An Operational Definition and Its Conversion Rate to Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[103]  N. Fayed,et al.  Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. , 2005, The American journal of psychiatry.

[104]  C Boesch,et al.  Versatile frequency domain fitting using time domain models and prior knowledge , 1998, Magnetic resonance in medicine.

[105]  S. Van Huffel,et al.  MRS signal quantitation: a review of time- and frequency-domain methods. , 2008, Journal of magnetic resonance.

[106]  D. Head,et al.  Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.

[107]  S. Love,et al.  Contributors to white matter damage in the frontal lobe in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.

[108]  Wolfgang Grodd,et al.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.

[109]  S. Blüml,et al.  Developmental changes in choline‐ and ethanolamine‐containing compounds measured with proton‐decoupled 31P MRS in in vivo human brain , 1999, Magnetic resonance in medicine.

[110]  Shi-Jiang Li,et al.  Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.

[111]  R. Gonzalez,et al.  Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. , 2005, AJNR. American journal of neuroradiology.

[112]  Stefan Klöppel,et al.  Automated tractography of the cingulate bundle in Alzheimer's disease: A multicenter DTI study , 2012, Journal of magnetic resonance imaging : JMRI.

[113]  S. Wisniewski,et al.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.

[114]  Bruce Fischl,et al.  Regional white matter volume differences in nondemented aging and Alzheimer's disease , 2009, NeuroImage.

[115]  G. Fein,et al.  Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. , 1996, Radiology.

[116]  M. Targosz-Gajniak,et al.  Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia , 2013, Journal of the Neurological Sciences.

[117]  R. Pintelon,et al.  A new FIR filter technique for solvent suppression in MRS signals. , 2009, Journal of magnetic resonance.

[118]  D. Budd,et al.  Presynaptic receptors and the control of glutamate exocytosis , 1996, Trends in Neurosciences.

[119]  A. Simmons,et al.  Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. , 2005, Archives of general psychiatry.

[120]  T. Ishihara,et al.  An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer’s disease , 2004, Acta Neuropathologica.

[121]  Dost Öngür,et al.  Quantification of J‐resolved proton spectra in two‐dimensions with LCModel using GAMMA‐simulated basis sets at 4 Tesla , 2009, NMR in biomedicine.

[122]  渡辺 俊之 Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging , 2011 .

[123]  M. Bozzali,et al.  Assessing Corpus Callosum Changes in Alzheimer's Disease: Comparison between Tract-Based Spatial Statistics and Atlas-Based Tractography , 2012, PloS one.

[124]  F. Lang,et al.  Up‐regulation of hypertonicity‐activated myo‐inositol transporter SMIT1 by the cell volume‐sensitive protein kinase SGK1 , 2008, The Journal of physiology.

[125]  A. Harwood,et al.  Lithium therapy and signal transduction. , 2000, Trends in pharmacological sciences.

[126]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[127]  J. Neale,et al.  N‐Acetylaspartylglutamate Inhibits Forskolin‐Stimulated Cyclic AMP Levels via a Metabotropic Glutamate Receptor in Cultured Cerebellar Granule Cells , 1993, Journal of neurochemistry.

[128]  K. Strange,et al.  In situ localization and osmotic regulation of the Na(+)-myo-inositol cotransporter in rat brain. , 1996, American Journal of Physiology.

[129]  R. Shulman,et al.  Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[130]  Masahiko Watanabe,et al.  Evidence for creatine biosynthesis in Müller glia , 2005, Glia.

[131]  Masahiko Watanabe,et al.  Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK‐Mi and CK‐B suggest a novel neuron–glial relationship for brain energy homeostasis , 2004, The European journal of neuroscience.

[132]  C. Jack,et al.  Risk of dementia in MCI , 2009, Neurology.

[133]  Clifford R. Jack,et al.  Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease , 2007, Neurobiology of Aging.

[134]  B. Fischl,et al.  White matter pathology isolates the hippocampal formation in Alzheimer's disease , 2010, Neurobiology of Aging.

[135]  B D Ross,et al.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. , 1995, The Journal of clinical investigation.

[136]  R. Gruetter,et al.  evelopmental and metabolic brain alterations in rats exposed to bisphenol during gestation and lactation , 2010 .

[137]  N. Schuff,et al.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.

[138]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[139]  B. Peterson,et al.  Spectral resolution amelioration by deconvolution (SPREAD) in MR spectroscopic imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[140]  H. Gertz,et al.  The prognosis of mild cognitive impairment in the elderly. , 1998, Journal of neural transmission. Supplementum.

[141]  G. Alexander,et al.  High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. , 1999, The American journal of psychiatry.

[142]  M. Aksenova,et al.  The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients , 1991, FEBS letters.

[143]  Erika Zambello,et al.  Evaluation of expression and function of the H+/myo-inositol transporter HMIT , 2009, BMC Cell Biology.

[144]  S. Van Huffel,et al.  Quantification of magnetic resonance spectroscopy signals with lineshape estimation , 2011 .

[145]  Stefan Neubauer,et al.  Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. , 2004, Human molecular genetics.

[146]  S. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[147]  R. Reilmann,et al.  Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease , 2010, Neurology.

[148]  W. Sherman,et al.  Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring. , 1977, Analytical biochemistry.

[149]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[150]  B. L. Miller,et al.  Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients , 2005, Neurology.

[151]  S. M. de la Monte,et al.  Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.

[152]  Role of Cytosolic Calcium-Dependent Phospholipase A2 in Alzheimer's Disease Pathogenesis , 2012, Molecular Neurobiology.

[153]  H. Henry,et al.  AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: A review , 2008, Journal of Inherited Metabolic Disease.

[154]  Linda Chang,et al.  Effects of age and sex on brain glutamate and other metabolites. , 2009, Magnetic resonance imaging.

[155]  Patrizia Mecocci,et al.  Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy , 2006, Neurobiology of Aging.

[156]  M. Sdika,et al.  Time‐domain semi‐parametric estimation based on a metabolite basis set , 2005, NMR in biomedicine.

[157]  S. Rose,et al.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[158]  P. Doraiswamy,et al.  Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? , 1998, The Journal of clinical psychiatry.

[159]  N Roberts,et al.  A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. , 2001, Cerebral cortex.

[160]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[161]  Declan G. M. Murphy,et al.  Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease , 2011, NeuroImage.

[162]  K. Strange,et al.  Osmoregulation of Na(+)-inositol cotransporter activity and mRNA levels in brain glial cells. , 1992, The American journal of physiology.

[163]  Sander Martens,et al.  Magnetic resonance spectroscopy in mild cognitive impairment: Systematic review and meta-analysis , 2013, Neuroscience & Biobehavioral Reviews.

[164]  J. Fisk,et al.  Five-Year Outcomes for Dementia Defined Solely by Neuropsychological Test Performance , 2003, Neuroepidemiology.